Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,220,180
-
Share change
-
+6,336
-
Total reported value
-
$6,341,093,799
-
Put/Call ratio
-
199%
-
Price per share
-
$121.48
-
Number of holders
-
315
-
Value change
-
-$32,435,953
-
Number of buys
-
142
-
Number of sells
-
193
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2016
As of 30 Sep 2016,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
315 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,220,180 shares.
The largest 10 holders included
FMR LLC, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, FIL Ltd, WESTFIELD CAPITAL MANAGEMENT CO LP, CADIAN CAPITAL MANAGEMENT, LP, Partner Fund Management, L.P., BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and JANUS CAPITAL MANAGEMENT LLC.
This page lists
316
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.